Search Tag: Michael L. Meyers

Executive Health Management

Nuvalent-appoints-michael-l-meyers-md-phd-to-board-of-directors

2022 06 Oct

Nuvalent, Inc, a clinical-stage biopharmaceutical company focused on creating  precisely  targeted therapies for clinically proven kinase targets in cancer announced the appointment of  Michael L. Meyers , M.D., Ph.D., to its Board of Directors. An experienced drug developer and medical oncologist who has contributed to the successful development and...Read more